What happens when you take yerba mate with MAOIs?
Yerba mate is a tea-like infusion made from the leaves of Ilex paraguariensis, traditionally consumed in Argentina, Paraguay, Uruguay, and southern Brazil. A standard cup delivers roughly 30 to 80 milligrams of caffeine plus theobromine and theophylline, the same family of methylxanthines found in coffee, tea, and cocoa. Yerba mate also contains a complex polyphenol profile, modest amounts of tyramine in some preparations, and trace compounds that have been described in older literature as weak monoamine oxidase inhibitors, though that effect is mild and not clinically meaningful at typical intakes.
Prescription MAOIs include phenelzine (Nardil), tranylcypromine (Parnate), isocarboxazid (Marplan), and selegiline in its oral form for Parkinson's (Eldepryl, Zelapar) and transdermal form for depression (Emsam). These drugs inhibit monoamine oxidase, the enzyme that breaks down norepinephrine, dopamine, serotonin, and dietary tyramine in the gut. When MAO is inhibited, dietary tyramine that would normally be metabolized in the gut wall and liver enters circulation, displaces norepinephrine from sympathetic nerve terminals, and produces a hypertensive response. The same mechanism applies to other sympathomimetics, including caffeine in high doses.
Why is this important?
Hypertensive crisis is the headline risk of any MAOI interaction. Severe blood pressure spikes can produce intracranial hemorrhage, stroke, myocardial infarction, and death. The classic trigger is a tyramine-rich food (aged cheese, cured meats, fermented soy, draft beer) but high-dose caffeine and any sympathomimetic also raise risk. Published reviews of MAOI dietary restrictions and drug interactions in The Primary Care Companion and CNS Spectrums note that while modest caffeine intake is generally tolerated, the combination of high caffeine load plus an MAOI can produce dangerous pressor responses, especially in patients with underlying hypertension or vascular disease.
Yerba mate sits in a problematic position. It is marketed as a healthy alternative to coffee and is commonly consumed in volumes that deliver several hundred milligrams of total methylxanthine per session in traditional gourd-and-bombilla service. Some traditionally fermented or aged yerba mate preparations also carry meaningful tyramine. A patient who has switched from coffee to yerba mate believing it is gentler may actually be increasing both their caffeine and tyramine exposure on a medication where both matter. The serotonergic risk is more theoretical at typical intakes but becomes more relevant if the patient is also using SAMe, St. John's wort, 5-HTP, or other serotonergic supplements alongside the MAOI.
What should you do?
Avoid yerba mate during MAOI treatment and during the two-week washout period after stopping a non-selective MAOI. The same rule applies to high-dose green tea extracts, kola nut, guarana, and any energy drink. If you need a hot beverage, herbal infusions without caffeine (rooibos, chamomile, peppermint, ginger) are safe choices. Decaffeinated coffee and tea are generally tolerated in moderation but still contain trace caffeine.
If you have been drinking yerba mate regularly, taper down before starting an MAOI rather than stopping abruptly, because caffeine withdrawal can produce headaches that mimic the very hypertensive symptoms you are trying to avoid. Tell your prescribing psychiatrist about all your dietary patterns including teas, supplements, and traditional foods, so the dietary restrictions can be tailored to your actual life. Seek emergency care immediately for severe sudden headache, especially at the back of the head, neck stiffness, chest pain, severe palpitations, sudden vision changes, sweating with a pounding heartbeat, or a home blood pressure reading above 180 over 110. These are signs of a hypertensive crisis.
Which specific products are affected?
Non-selective MAOIs in this category include phenelzine (Nardil), tranylcypromine (Parnate), and isocarboxazid (Marplan). Selegiline at low transdermal doses (Emsam 6 mg/24 hr) is selective for MAO-B and does not require strict dietary restrictions, but at higher doses (9 and 12 mg/24 hr patches) it loses selectivity and the same precautions apply. Oral selegiline at higher doses for atypical use carries similar concerns. Rasagiline (Azilect) and safinamide are selective MAO-B inhibitors used in Parkinson's; they carry warnings but the dietary restrictions are less strict. Linezolid (Zyvox) and methylene blue have MAOI activity and the same dietary and supplement caution applies. On the yerba mate side, the relevant products are loose-leaf yerba mate, brand-name mate teas (Guayaki, EcoTeas, Cruz de Malta, Taragui, CBSe), bottled yerba mate energy drinks, and any energy drink listing Ilex paraguariensis as an ingredient.
The bottom line
Yerba mate is not a gentle herbal tea in the context of MAOI therapy. Its caffeine and methylxanthine load can amplify the pressor response of monoamine oxidase inhibition, and traditional service sizes can deliver high doses without the user noticing. The safe move is to avoid yerba mate entirely while on a non-selective MAOI and through the two-week washout period after stopping. Switch to caffeine-free herbal infusions, tell your prescriber about your full dietary pattern, and treat severe headache, chest pain, or a major blood pressure spike as a medical emergency.